These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36479885)

  • 1. Real-World Treatment Patterns and Treatment Benefits among Adult Patients with Atopic Dermatitis: Results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey.
    Augustin M; Costanzo A; Pink A; Seneschal J; Schuster C; Mert C; Guerreiro M; Tietz N; Grond S; De Bruin-Weller M
    Acta Derm Venereol; 2022 Dec; 102():adv00830. PubMed ID: 36479885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessment.
    Wei W; Ghorayeb E; Andria M; Walker V; Schnitzer J; Kennedy M; Chen Z; Belland A; White J; Silverberg JI
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):381-388.e2. PubMed ID: 31325566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden, Control, and Treatment of Moderate to Severe Atopic Dermatitis in 2021: A United States Patient Survey Study.
    Lio P; Mackie D; Bates D; Mulvihill E; Patel M; Kim Y; Shi V
    J Drugs Dermatol; 2023 Feb; 22(2):119-131. PubMed ID: 36745377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis.
    Anderson P; Austin J; Lofland JH; Piercy J; Joish VN
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1571-1585. PubMed ID: 34268709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' and Caregivers' Experiences With Atopic Dermatitis-Related Burden, Medical Care, and Treatments in 8 Countries.
    Capozza K; Funk M; Hering M; Lang J; Merhand S; Manion R; Orevillo K; Picozza M; Proctor A; Schwennesen T; Begolka WS; Tullos K; Talent C; Tu M; Vastrup AS; Schwartz A
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):264-273.e1. PubMed ID: 36332836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
    Kimball AB; Delevry D; Yang M; Chuang CC; Wang Z; Bégo-Le-Bagousse G; Martins B; Wu E; Shumel B; Wang J; Sierka D; Chao J; Strober B
    Dermatol Ther (Heidelb); 2023 Sep; 13(9):2107-2120. PubMed ID: 37552431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of adult atopic dermatitis and unmet needs with existing therapies.
    Bacci ED; Correll JR; Pierce EJ; Atwater AR; Dawson Z; Begolka WS; Butler L
    J Dermatolog Treat; 2023 Dec; 34(1):2202288. PubMed ID: 37042571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort.
    Silverberg JI; Simpson B; Abuabara K; Guttman-Yassky E; Calimlim B; Wegzyn C; Krueger W; Gamelli A; Munoz B; Faller RW; Crawford JM; Grada A; Eichenfield LF;
    J Am Acad Dermatol; 2023 Sep; 89(3):519-528. PubMed ID: 37150299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Perception of Disease Severity and Treatment Outcomes for Children and Adolescents with Atopic Dermatitis in Emerging Economies.
    Tang MBY; Fatani M; Wiggins S; Maspero J
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):999-1013. PubMed ID: 35349107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.
    Katoh N; Saeki H; Kataoka Y; Etoh T; Teramukai S; Takagi H; Tajima Y; Ardeleanu M; Rizova E; Arima K;
    J Dermatol; 2019 Apr; 46(4):290-300. PubMed ID: 30756423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient Survey.
    Silverberg JI; Mohawk JA; Cirulli J; Nograles K; Punzalan JC; Kelly KM; Kim BS; Guttman-Yassky E; Lebwohl M
    Dermatitis; 2023; 34(2):135-144. PubMed ID: 36917518
    [No Abstract]   [Full Text] [Related]  

  • 14. Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Pierce E; Feely M; Atwater AR; Schrader A; Jones EA; Dave SS; Simpson EL
    J Dermatolog Treat; 2023 Dec; 34(1):2246601. PubMed ID: 37691405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
    Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
    J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Atopic Dermatitis.
    Torres T; Ferreira EO; Gonçalo M; Mendes-Bastos P; Selores M; Filipe P
    Acta Med Port; 2019 Sep; 32(9):606-613. PubMed ID: 31493365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Reported Disease Burden and Unmet Therapeutic Needs in Atopic Dermatitis.
    Bacci E; Rentz A; Correll J; Pierce E; DeLozier A; Rueda M; Begolka W; Butler L
    J Drugs Dermatol; 2021 Nov; 20(11):1222-1230. PubMed ID: 34784136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study.
    Torrelo A; Ortiz J; Alomar A; Ros S; Pedrosa E; Cuervo J
    Actas Dermosifiliogr; 2013 Jun; 104(5):409-17. PubMed ID: 23665434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of atopic eczema.
    Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.